A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned Ann-Margret Ervin, Rupert W. Strauss, Mohamed I. Ahmed, David Birch, Janet Cheetham, Frederick L. Ferris III, Michael S. Ip, Glenn J. Jaffe, Maureen G. Maguire, Etienne M. Schönbach, SriniVas R. Sadda, Sheila K. West, and Hendrik P.N. Scholl; for the ProgStar Study Group 1 Wilmer Eye Institute, The Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA 2 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA 3 Moorfields Eye Hospital NHS Foundation Trust, and UCL Institute of Ophthalmology, University College London, London, UK 4 Department of Ophthalmology, Kepler University Clinic, Linz, Austria 5 Department of Ophthalmology, Medical University Graz, Graz, Austria 6 Retina Foundation of the Southwest, Dallas, TX, USA 7 Foundation Fighting Blindness Clinical Research Institute, Columbia, MD, USA 8 National Eye Institute, National Institutes of Health, Bethesda, MD, USA 9 Doheny Imaging Reading Center, Doheny Eye Institute, David Geffen School of Medicine at University of California Los Angeles, CA, USA 10 Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA 11 Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA 12 Case Western Reserve University, Cleveland, OH, USA 13 Department of Ophthalmology, University of Basel, Basel, Switzerland 14 Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland